Motley Fool Australia

ResApp Health Ltd (ASX: RAP) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $51.98 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 764.37 million
Earnings per share -0.011
Dividend per share N/A
Year To Date Return -20.00%
Earnings Yield N/A
Franking N/A

ResApp Health (ASX: RAP) Latest News

Fall in ASX share price represented by white arrow pointing down

Why Corp Travel Management, IGO, Limeade, & ResApp are tumbling lower

More »

ASX stock of the day: Why ResApp Heath (ASX:RAP) shares are soaring

More »

asx shares higher

Why Afterpay, Piedmont Lithium, ResApp, & Santos are charging higher

More »

jump in asx share price represented by man jumping in the air in celebration

ResApp (ASX:RAP) share price jumps 19% on AstraZeneca deal

More »

covid asx share price represented by man in face mask giving thumbs up

ResApp (ASX:RAP) share price jumps on COVID-19 app plans

More »

business share price

Why Flight Centre, Qantas, ResApp, & Volpara are racing higher

More »

falling asx share price represented by woman making sad face

Why the ResApp (ASX:RAP) share price is sinking 5% today

More »

increase in asx medical software share price represented by doctor making excited hands up gesture

Why the ResApp (ASX:RAP) share price opened 10% higher today

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About ResApp Health Ltd (ASX: RAP)

ResApp Health Ltd is engaged in development and commercialization of the ResApp technology for the purpose of providing health care solutions for respiratory disease. The company's solutions are designed to be easily integrated into existing telehealth solutions and it is working on apps to provide respiratory disease diagnosis and management directly to consumers and healthcare providers. Its products are for Acute Disease Diagnosis; for Chronic Disease Management; and for Sleep Apnoea.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
07 Apr 2021 $0.07 $0.00 0.00% 1,836,903 $0.07 $0.07 $0.07
06 Apr 2021 $0.07 $0.00 0.00% 521,992 $0.07 $0.07 $0.07
01 Apr 2021 $0.07 $0.00 0.00% 1,030,569 $0.07 $0.07 $0.07
31 Mar 2021 $0.07 $0.00 0.00% 1,060,071 $0.07 $0.07 $0.07
30 Mar 2021 $0.07 $0.00 0.00% 1,719,871 $0.07 $0.07 $0.07
29 Mar 2021 $0.07 $0.00 0.00% 1,455,858 $0.07 $0.07 $0.07
26 Mar 2021 $0.07 $0.00 0.00% 703,256 $0.07 $0.07 $0.07
25 Mar 2021 $0.07 $0.00 0.00% 1,303,636 $0.07 $0.07 $0.07
24 Mar 2021 $0.07 $0.00 0.00% 3,745,446 $0.07 $0.07 $0.07
23 Mar 2021 $0.07 $0.00 0.00% 1,292,928 $0.08 $0.08 $0.07
22 Mar 2021 $0.07 $0.00 0.00% 1,832,720 $0.08 $0.08 $0.07
19 Mar 2021 $0.07 $0.00 0.00% 2,267,983 $0.08 $0.08 $0.07
18 Mar 2021 $0.07 $0.00 0.00% 1,629,245 $0.07 $0.08 $0.07
17 Mar 2021 $0.07 $-0.01 -12.82% 2,870,344 $0.08 $0.08 $0.07
16 Mar 2021 $0.08 $0.01 13.89% 8,466,111 $0.07 $0.08 $0.07
15 Mar 2021 $0.07 $0.00 0.00% 9,075,942 $0.07 $0.07 $0.07
12 Mar 2021 $0.07 $0.01 17.24% 19,703,285 $0.07 $0.07 $0.06
11 Mar 2021 $0.06 $0.00 0.00% 3,869,250 $0.06 $0.06 $0.06
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
15 Mar 2021 Roger Aston Buy 290 $20,300
15 Mar 2021 Christopher Ntoumenopoulos Buy 500 $35,500
15 Mar 2021 Anthony (Tony) Keating Buy 225 $16,200
02 Dec 2020 Michael Stein Issued 500 $45,000
02 Jul 2020 Anthony (Tony) Keating Sell 10 $1,500,000
01 Jul 2020 Anthony (Tony) Keating Exercise 20 $1,375,000
01 Jul 2020 Anthony (Tony) Keating Buy 20 $1,375,000
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Dr Roger Aston Non-Executive Chairman,Non-Executive Director Jul 2015
Dr Michael Stein Non-Executive Director Apr 2020
Mr Christopher Ntoumenopoulos Non-Executive Director Jan 2015
Dr Anthony (Tony) Keating Chief Executive Officer,Managing Director Jul 2015
Ms Nicki Farley Company Secretary
Nicki Farley Company Secretary

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 69,891,549 9.26%
Freeman Road Pty Ltd 40,500,000 5.36%
J P Morgan Nominees Australia Pty Limited 17,600,530 2.33%
Bnp Paribas Nominees Pty Ltd 17,266,887 2.29%
Mr Frank Weng Thong Chew 13,168,000 1.74%
Mr Anthony James Keating 10,000,000 1.32%
Equimetrixs Pty Ltd 8,437,500 1.12%
Narhex Life Sciences Developments Pty Ltd 7,997,005 1.06%
Cem International (Asia) Pty Ltd 7,849,888 1.04%
Mr Yongsheng Peng & Mrs Yuezhen Xie 4,798,502 0.64%
Let Superannuation Pty Ltd 4,444,103 0.59%
Citicorp Nominees Pty Limited 4,436,079 0.59%
Mr Victor John Wilk 4,400,000 0.58%
Mr Trent Antony Goodrick 4,000,000 0.53%
Wilk Holdings Pty Ltd 4,000,000 0.53%
Queensland Forest Industries Pty Ltd 3,806,830 0.50%
Gardmac Pty Ltd 3,681,395 0.49%
Mr Jason Dennis Roberts 3,431,954 0.45%
Dr Geoffrey Waring 3,303,764 0.44%
Sobol Capital Pty Ltd 3,109,375 0.41%
Show more